The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - MSD
Research Funding - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bayer; EUSA Pharma
Prognostic biomarkers of systemic inflammation in patients on active surveillance for metastatic renal cell carcinoma (mRCC): A biobank analysis.
 
Vishwani Chauhan
No Relationships to Disclose
 
Jahangeer Malik
Honoraria - EUSA Pharma; Pfizer
Consulting or Advisory Role - Eisai
 
Aravindhan Sundaramurthy
No Relationships to Disclose
 
Stefan N. Symeonides
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ellipses Pharma (Inst); EUSA Pharma (Inst); MedAnnex (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Vaccitech (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); Novartis (Inst)
Research Funding - BiolineRx (Inst); BioNTech (Inst); Boston Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Nouscom (Inst); Nucana (Inst); Sapience Therapeutics (Inst); Sierra Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Mark Stares
No Relationships to Disclose